RECRUITING

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.

Official Title

Age-dependent Heterogeneity in the Efficacy of Prophylaxis With Enoxaparin Against Catheter-associated Thrombosis in Critically Ill Children

Quick Facts

Study Start:2022-05-11
Study Completion:2026-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04924322

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

E. Vincent Faustino, MD, MHS
CONTACT
203-785-4651
vince.faustino@yale.edu
Tara McPartland, MSW, MPH
CONTACT
203-737-7173
tara.mcpartland@yale.edu

Principal Investigator

E. Vincent Faustino, MD, MHS
PRINCIPAL_INVESTIGATOR
Associate Professor of Pediatrics, Yale School of Medicine

Study Locations (Sites)

Children's of Alabama
Birmingham, Alabama, 35233
United States
Children's Hospital Colorado
Aurora, Colorado, 80045
United States
Yale-New Haven Children's Hospital
New Haven, Connecticut, 06520
United States
Johns Hopkins All Children's
Saint Petersburg, Florida, 33701
United States
Children's Hospital of Illinois at OSF Saint Francis Medical Center
Peoria, Illinois, 61637
United States
Stead Family Children's Hospital
Iowa City, Iowa, 52242
United States
Children's Hospital St. Louis
Saint Louis, Missouri, 63110
United States
Hassenfeld Children's Hospital
New York, New York, 10016
United States
New York Presbyterian Hospital
New York, New York, 10065
United States
Golisano Children's Hospital
Rochester, New York, 14642
United States
Maria Fareri Children's Hospital
Valhalla, New York, 10595
United States
Nationwide Children's Hospital
Columbus, Ohio, 43205
United States
University of Oklahoma
Oklahoma City, Oklahoma, 73104
United States
Penn State Hershey Children's Hospital
Hershey, Pennsylvania, 17033
United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104
United States
Children's Hospital of Richmond
Richmond, Virginia, 23219
United States
Children's Hospital Wisconsin
Milwaukee, Wisconsin, 53226
United States

Collaborators and Investigators

Sponsor: Yale University

  • E. Vincent Faustino, MD, MHS, PRINCIPAL_INVESTIGATOR, Associate Professor of Pediatrics, Yale School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-11
Study Completion Date2026-07-31

Study Record Updates

Study Start Date2022-05-11
Study Completion Date2026-07-31

Terms related to this study

Keywords Provided by Researchers

  • child
  • critical illness
  • venous thromboembolism
  • enoxaparin
  • thrombin generation
  • bleed

Additional Relevant MeSH Terms

  • Deep Venous Thrombosis